Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Data Coordinating Center for Autism and Other Development Disabilities Research, Program Announcement Number (PA) DD09-002; Epidemiologic and Surveillance and Epidemiologic Research of Duchenne and Becker Muscular Dystrophy, PA DD06-002, 10593-10594 [E9-5117]

Download as PDF 10593 Federal Register / Vol. 74, No. 46 / Wednesday, March 11, 2009 / Notices protect the health of the public under the authority of section 301 of the Public Health Service Act (42 U.S.C.). This information collection request also includes the Passenger Locator Information Form. The Passenger Locator Information Form is used to collect reliable information that assists quarantine officers in locating, in a timely manner, those passengers and crew who are exposed to communicable diseases of public health significance while traveling on a conveyance. HHS delegates authority to CDC to conduct introduction and spread of communicable diseases into the United States with a minimum of recordkeeping and reporting as well as a minimum of interference with trade and travel. Respondents include airline pilots, ships’ captains, importers, and travelers. The nature of the quarantine response dictates which forms are completed by whom. There are no costs to respondents except for their time to complete the forms. quarantine control measures. Currently, with the exception of rodent inspections and the cruise ship sanitation program, inspections are performed only on those vessels and aircraft which report illness prior to arrival or when illness is discovered upon arrival. Other inspection agencies assist quarantine officers in public health screening of persons, pets, and other importations of public health significance and make referrals to the Public Health Service when indicated. These practices and procedures assure protection against the ESTIMATE OF ANNUALIZED BURDEN HOURS Number of respondents Citation Average burden per respondent (in hours) Number of responses per respondent Total burden 71.21 Radio Report of death/illness .............................................................. 71.33(c) Report by persons in isolation or surveillance ................................ 71.35 Report of death/illness in port ............................................................. Locator Form used in an outbreak of public health significance .................... Locator Form used for reporting of an ill passenger(s) ................................... 71.51(b)(3) Admission of cats/dogs; death/illness ........................................ 71.51(d) Dogs/cats: Certification of Confinement, Vaccination .................... 71.52(d) Turtle Importation Permits .............................................................. 71.53(d) Importer Registration—Nonhuman Primates .................................. 71.53(e) Recordkeeping ................................................................................ 9,500 11 5 2,700,000 800 5 1,200 10 40 30 1 1 1 1 1 1 1 1 1 4 2/60 3/60 30/60 5/60 5/60 3/60 15/60 30/60 10/60 30/60 317 1 3 225,000 67 1 300 5 7 60 Total .......................................................................................................... ........................ ........................ ........................ 225,761 Dated: March 3, 2009. Maryam I. Daneshvar, Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E9–5116 Filed 3–10–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: February 3, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–5152 Filed 3–10–09; 8:45 am] Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Health Statistics: Notice of Charter Renewal rwilkins on PROD1PC63 with NOTICES The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. 17:01 Mar 10, 2009 Jkt 217001 PO 00000 Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Data Coordinating Center for Autism and Other Development Disabilities Research, Program Announcement Number (PA) DD09–002; Epidemiologic and Surveillance and Epidemiologic Research of Duchenne and Becker Muscular Dystrophy, PA DD06–002 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. BILLING CODE 4163–18–P This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Board of Scientific Counselors, National Center for Health Statistics, Department of Health and Human Services, has been renewed for a 2-year period through January 19, 2011. For information, contact Virginia Cain, Ph.D., Executive Secretary, Board of Scientific Counselors, National Center for Health Statistics, Department of Health and Human Services, 3311 Toledo Road, Room 7204, Mailstop P08, Hyattsville, Maryland 20782, telephone 301/458–4395 or fax 301/458–4020. VerDate Nov<24>2008 DEPARTMENT OF HEALTH AND HUMAN SERVICES Time and Date: 1 p.m.–4 p.m., March 26, 2009 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of the application received in response to ‘‘Data Coordinating Center for Autism and Other Development Disabilities Frm 00066 Fmt 4703 Sfmt 4703 E:\FR\FM\11MRN1.SGM 11MRN1 10594 Federal Register / Vol. 74, No. 46 / Wednesday, March 11, 2009 / Notices Research, PA DD09–002; and the supplements received for Epidemiologic and Surveillance and Epidemiologic Research of Duchenne and Becker Muscular Dystrophy, PA DD06–002.’’ For Further Information Contact: Geneva L. Cashaw, Designated Federal Official, CDC, 4770 Buford Highway, NE., Mailstop K–92, Telephone (770) 488–8390. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: March 4, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–5117 Filed 3–10–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Grants for Injury Control Research Centers, CE09–001 rwilkins on PROD1PC63 with NOTICES In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 9 a.m.–12 p.m., March 30, 2009 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the secondary review of applications received in response to Funding Opportunity Announcement, CE09–001, Grants for Injury Control Research Centers. For Further Information Contact: Gwendolyn Cattledge, Ph.D., Deputy Associate Director for Science, NCIPC, CDC, 4770 Buford Highway, NE., MS F–62, Atlanta, GA 30341, Telephone (770) 488– 4665. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. VerDate Nov<24>2008 17:01 Mar 10, 2009 Jkt 217001 Dated: March 2, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–5157 Filed 3–10–09; 8:45 am] Dated: February 26, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–5156 Filed 3–10–09; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Administration for Children and Families National Center for Injury Prevention and Control Initial Review Group (NCIPC, IRG) Proposed Information Collection Activity; Comment Request In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting: Times and Date: 8:30 a.m.–9 a.m., April 2, 2009 (Open). 9 a.m.–6 p.m., April 2, 2009 (Closed). Place: Embassy Suites of Buckhead, 3285 Peachtree Road, Atlanta, GA 30305, telephone: (404) 261–7733. Status: Portions of the meetings will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to section 10(d) of Public Law 92–463. Purpose: This group is charged with providing advice and guidance to the Secretary, Department of Health and Human Services, and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of individual research grant applications submitted in response to Fiscal Year 2009 Requests for Applications related to the following individual research announcement: RFA–CE–09–004 ‘‘Unintentional Poisoning from Prescription Drug Overdose in Adults (R21).’’ Agenda items are subject to change as priorities dictate. For Further Information Contact: Jane Suen, Dr.P.H., NCIPC, CDC, 4770 Buford Highway, NE., Mailstop F–62, Atlanta, Georgia 30341, telephone: (770) 488–4281; fax: (770) 488–4422. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 Proposed Projects Title: State Plan for Foster Care and Adoption Assistance—Title IV–E. OMB No.: 0980–0141. Description: A title IV–E plan is required by section 471 part IV–E of the Social Security Act (the Act) for each public child welfare agency requesting Federal funding for foster care, adoption assistance and guardianship assistance under the Act. The title IV–E plan provides assurances the programs will be administered in conformity with the specific requirements stipulated in title IV–E. The plan must include all applicable State statutory, regulatory, or policy references and citations for each requirement as well as supporting documentation. A title IV–E agency may use the pre-print format prepared by the Children’s Bureau of the Administration for Children and Families or a different format, on the condition that the format used includes all of the title IV–E State plan requirements of the law. Public Law 110–351, the Fostering Connections to Success and Increasing Adoptions Act of 2008, created a new title IV–E plan option to provide a Guardianship Assistance Program for relatives of children in foster care (section 471(a)(28) of the Act). The Guardianship Assistance program was made effective for States upon enactment of Public Law 110–351 (October 7, 2008). Effective October 1, 2009, Public Law 110–351 will allow Tribes, Tribal organizations and Tribal consortia to directly operate title IV–E programs for foster care maintenance payments, adoption assistance and kinship guardianship assistance. The law also made a number of other changes to title IV–E plan requirements and eligibility criteria. The law’s provisions expanding the scope of the title IV–E program necessitates a revision of the preprint. Respondents: State and Territorial Agencies (State Agencies) administering E:\FR\FM\11MRN1.SGM 11MRN1

Agencies

[Federal Register Volume 74, Number 46 (Wednesday, March 11, 2009)]
[Notices]
[Pages 10593-10594]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-5117]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Data Coordinating Center for Autism and Other 
Development Disabilities Research, Program Announcement Number (PA) 
DD09-002; Epidemiologic and Surveillance and Epidemiologic Research of 
Duchenne and Becker Muscular Dystrophy, PA DD06-002

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 1 p.m.-4 p.m., March 26, 2009 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of the application received in response 
to ``Data Coordinating Center for Autism and Other Development 
Disabilities

[[Page 10594]]

Research, PA DD09-002; and the supplements received for 
Epidemiologic and Surveillance and Epidemiologic Research of 
Duchenne and Becker Muscular Dystrophy, PA DD06-002.''
    For Further Information Contact: Geneva L. Cashaw, Designated 
Federal Official, CDC, 4770 Buford Highway, NE., Mailstop K-92, 
Telephone (770) 488-8390.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: March 4, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E9-5117 Filed 3-10-09; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.